Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Tectonic Therapeutic, Inc. (TECX) had Stock-Based Compensation of $3.21M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-25.24M |
|
-- |
|
-- |
|
$27.30M |
|
$-27.30M |
|
$2.06M |
|
$-25.24M |
|
$-25.24M |
|
$-25.24M |
|
$-25.24M |
|
$-25.24M |
|
$-25.24M |
|
$-27.30M |
|
$-27.00M |
|
18.77M |
|
18.77M |
|
$-1.34 |
|
$-1.34 |
|
| Balance Sheet Financials | |
$239.89M |
|
$1.02M |
|
$6.69M |
|
$246.58M |
|
$12.96M |
|
$0.02M |
|
$3.20M |
|
$16.16M |
|
$230.42M |
|
$230.42M |
|
$230.42M |
|
18.83M |
|
| Cash Flow Statement Financials | |
$-18.41M |
|
$-0.02M |
|
$0.85M |
|
$254.87M |
|
$237.38M |
|
$-17.49M |
|
|
Stock-Based Compensation |
$3.21M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.51 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.95% |
|
-10.95% |
|
-10.24% |
|
-10.95% |
|
$12.24 |
|
$-0.98 |
|
$-0.98 |
|